Comprehensive assessment of targetable alterations in lung adenocarcinoma samples with limited material using MSK-IMPACT, a clinical, hybrid capture-based, next-generation sequencing (NGS) assay Meeting Abstract


Authors: Arcila, M. E.; Yu, H. A.; Drilon, A. E.; Riely, G. J.; Zehir, A.; Sadowska, J.; Hyman, D. M.; Kris, M. G.; Berger, M. F.; Ladanyi, M.
Abstract Title: Comprehensive assessment of targetable alterations in lung adenocarcinoma samples with limited material using MSK-IMPACT, a clinical, hybrid capture-based, next-generation sequencing (NGS) assay
Meeting Title: 51st Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 33
Issue: 15 Suppl.
Meeting Dates: 2015 May 29-Jun 2
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2015-05-20
Language: English
ACCESSION: WOS:000358036904539
PROVIDER: wos
DOI: 10.1200/jco.2015.33.15_suppl.e22160
Notes: Meeting Abstract: e22160 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Helena Alexandra Yu
    288 Yu
  2. Marc Ladanyi
    1332 Ladanyi
  3. Gregory J Riely
    604 Riely
  4. David Hyman
    354 Hyman
  5. Ahmet Zehir
    344 Zehir
  6. Michael Forman Berger
    768 Berger
  7. Maria Eugenia Arcila
    669 Arcila
  8. Mark Kris
    872 Kris
  9. Alexander Edward Drilon
    635 Drilon